Zongertinib
Drug timelines are a Plus or Pro feature.
15 regulatory and trial events tracked for Zongertinib, covering 2025-08-15 to 2026-06-02. Get the full timeline:
Most recent: Clinical Trial Update: Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment [Phase 3]